Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Insulet Corporation (PODD)

Surgical & Medical Instruments & Apparatus

https://www.insulet.com

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

100 NAGOG PARK
ACTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/15/2007

Market Cap

13,518,618,978

Shares Outstanding

69,830,000

Weighted SO

69,827,619

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

DXCM --.--%

IART --.--%

SENS --.--%

EW --.--%

TNDM --.--%

ABT --.--%

ALGN --.--%

SYK --.--%

SWAV --.--%

Beta

1.1540

Last Div

0.0000

Range

125.82-223.56

Chg

-2.2250

Avg Vol

728550

Mkt Cap

13518618978

Exch

NASDAQ

Country

US

Phone

978 600 7000

DCF Diff

265.8157

DCF

-72.7457

Div Yield

0.0000

P/S

7.2188

EV Multiple

60.3781

P/FV

13.5300

Div Yield %

0.0000

P/E

34.1723

PEG

1.4727

Payout

0.0000

Current Ratio

3.5619

Quick Ratio

2.6753

Cash Ratio

1.4722

DSO

67.9441

DIO

273.9566

Op Cycle

341.9008

DPO

48.8277

CCC

293.0730

Gross Margin

0.6934

Op Margin

0.1549

Pretax Margin

0.1428

Net Margin

0.2111

Eff Tax Rate

-0.5398

ROA

0.1372

ROE

0.5053

ROCE

0.1211

NI/EBT

1.4778

EBT/EBIT

0.9221

EBIT/Rev

0.1549

Debt Ratio

0.4851

D/E

1.4000

LT Debt/Cap

0.5766

Total Debt/Cap

0.5833

Int Coverage

-6.9402

CF/Debt

0.2039

Equity Multi

2.8862

Rec Turnover

5.3721

Pay Turnover

7.4753

Inv Turnover

1.3323

FA Turnover

2.7625

Asset Turnover

0.6499

OCF/Share

4.0678

FCF/Share

2.5991

Cash/Share

11.7182

OCF/Sales

0.1522

FCF/OCF

0.6389

CF Coverage

0.2039

ST Coverage

7.5198

CapEx Coverage

2.7697

Div&CapEx Cov

2.7697

P/BV

13.5300

P/B

13.5300

P/S

7.2188

P/E

34.1723

P/FCF

74.2373

P/OCF

47.3976

P/CF

47.3976

PEG

1.4727

P/S

7.2188

EV Multiple

60.3781

P/FV

13.5300

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jul 24, 14:31 Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research MarketWatch Jan 13, 06:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 09, 09:13 Here are Wall Street’s favorite stocks in the sector expected to grow profits the most in 2024 MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains MarketWatch Jan 06, 11:00 Ozempic and other weight-loss drugs' popularity set these stocks up for big gains

Revenue Product Segmentation